Skip to main content
Log in

Prevention of venous thromboembolism in patients with stroke—enoxaparin vs unfractionated heparin

  • Practice Point
  • Published:

From Nature Clinical Practice Neurology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Kelly J et al. (2001) Venous thromboembolism after acute stroke. Stroke 32: 262–267

    Article  CAS  Google Scholar 

  2. Geerts WH et al. (2004) Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (Suppl 3): S338–S400

    Article  Google Scholar 

  3. Kassai B et al. (2005) The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests. J Clin Epidemiol 58: 1042–1051

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bernstein, R. Prevention of venous thromboembolism in patients with stroke—enoxaparin vs unfractionated heparin. Nat Rev Neurol 3, 542–543 (2007). https://doi.org/10.1038/ncpneuro0613

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0613

  • Springer Nature Limited

Navigation